Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

CXCR3/CCR5 pathways in metastatic melanoma patients treated with adoptive therapy and interleukin-2.

Bedognetti D, Spivey TL, Zhao Y, Uccellini L, Tomei S, Dudley ME, Ascierto ML, De Giorgi V, Liu Q, Delogu LG, Sommariva M, Sertoli MR, Simon R, Wang E, Rosenberg SA, Marincola FM.

Br J Cancer. 2013 Oct 29;109(9):2412-23. doi: 10.1038/bjc.2013.557. Epub 2013 Oct 15.

2.

T lymphocyte recruitment into renal cell carcinoma tissue: a role for chemokine receptors CXCR3, CXCR6, CCR5, and CCR6.

Oldham KA, Parsonage G, Bhatt RI, Wallace DM, Deshmukh N, Chaudhri S, Adams DH, Lee SP.

Eur Urol. 2012 Feb;61(2):385-94. doi: 10.1016/j.eururo.2011.10.035. Epub 2011 Nov 4.

PMID:
22079021
3.

Pro-inflammatory chemokine-chemokine receptor interactions within the Ewing sarcoma microenvironment determine CD8(+) T-lymphocyte infiltration and affect tumour progression.

Berghuis D, Santos SJ, Baelde HJ, Taminiau AH, Egeler RM, Schilham MW, Hogendoorn PC, Lankester AC.

J Pathol. 2011 Feb;223(3):347-57. doi: 10.1002/path.2819. Epub 2010 Dec 10.

PMID:
21171080
5.
6.

Selective infiltration of CCR5(+)CXCR3(+) T lymphocytes in human colorectal carcinoma.

Musha H, Ohtani H, Mizoi T, Kinouchi M, Nakayama T, Shiiba K, Miyagawa K, Nagura H, Yoshie O, Sasaki I.

Int J Cancer. 2005 Oct 10;116(6):949-56.

7.

Liver inflammation in a mouse model of Th1 hepatitis despite the absence of invariant NKT cells or the Th1 chemokine receptors CXCR3 and CCR5.

Cripps JG, Celaj S, Burdick M, Strieter RM, Gorham JD.

Lab Invest. 2012 Oct;92(10):1461-71. doi: 10.1038/labinvest.2012.104. Epub 2012 Aug 20.

8.

Coexpression of chemokine receptors CCR5, CXCR3, and CCR4 and ligands for P- and E-selectin on T lymphocytes of patients with juvenile idiopathic arthritis.

Issekutz AC, Quinn PJ, Lang B, Ramsey S, Huber AM, Rowter D, Karkada M, Issekutz TB.

Arthritis Rheum. 2011 Nov;63(11):3467-76. doi: 10.1002/art.30521.

9.

CXCR3 and CCR5 positive T-cell recruitment in acute human renal allograft rejection.

Panzer U, Reinking RR, Steinmetz OM, Zahner G, Sudbeck U, Fehr S, Pfalzer B, Schneider A, Thaiss F, Mack M, Conrad S, Huland H, Helmchen U, Stahl RA.

Transplantation. 2004 Nov 15;78(9):1341-50.

PMID:
15548973
10.

Melanoma Induces, and Adenosine Suppresses, CXCR3-Cognate Chemokine Production and T-cell Infiltration of Lungs Bearing Metastatic-like Disease.

Clancy-Thompson E, Perekslis TJ, Croteau W, Alexander MP, Chabanet TB, Turk MJ, Huang YH, Mullins DW.

Cancer Immunol Res. 2015 Aug;3(8):956-67. doi: 10.1158/2326-6066.CIR-15-0015. Epub 2015 Jun 5.

11.

CXCR3 and CCR5 chemokines in induced sputum from patients with COPD.

Costa C, Rufino R, Traves SL, Lapa E Silva JR, Barnes PJ, Donnelly LE.

Chest. 2008 Jan;133(1):26-33. Epub 2007 Oct 9.

PMID:
17925429
12.

Serum chemokine receptor CXCR3 ligands are associated with progression, organ dysfunction and complications of chronic liver diseases.

Tacke F, Zimmermann HW, Berres ML, Trautwein C, Wasmuth HE.

Liver Int. 2011 Jul;31(6):840-9. doi: 10.1111/j.1478-3231.2011.02504.x. Epub 2011 Mar 10.

PMID:
21645215
13.

Analysis of NK cells and chemokine receptors in tumor infiltrating CD4 T lymphocytes in human renal carcinomas.

Cózar JM, Canton J, Tallada M, Concha A, Cabrera T, Garrido F, Ruiz-Cabello Osuna F.

Cancer Immunol Immunother. 2005 Sep;54(9):858-66. Epub 2005 May 11.

PMID:
15887015
14.

Non-redundant requirement for CXCR3 signalling during tumoricidal T-cell trafficking across tumour vascular checkpoints.

Mikucki ME, Fisher DT, Matsuzaki J, Skitzki JJ, Gaulin NB, Muhitch JB, Ku AW, Frelinger JG, Odunsi K, Gajewski TF, Luster AD, Evans SS.

Nat Commun. 2015 Jun 25;6:7458. doi: 10.1038/ncomms8458.

15.

CXCR3, CCR5, and CRTH2 Chemokine Receptor Expression in Lymphocytes Infiltrating Thyroid Nodules with Coincident Hashimoto's Thyroiditis Obtained by Fine Needle Aspiration Biopsy.

Jiskra J, Antošová M, Krátký J, Vítková H, Límanová Z, Marečková H, Potluková E.

J Immunol Res. 2016;2016:2743614. Epub 2016 Oct 31.

16.

Expression of DARC, CXCR3 and CCR5 in giant cell arteritis.

Brühl H, Vielhauer V, Weiss M, Mack M, Schlöndorff D, Segerer S.

Rheumatology (Oxford). 2005 Mar;44(3):309-13. Epub 2004 Nov 30. Erratum in: Rheumatology (Oxford). 2005 Apr;44(4):569.

PMID:
15572394
17.

Relationship between expression of chemokine receptors CCR3, CCR5 and CXCR3 on CD4(+) T cells and spontaneous abortion in mice.

Jiang PJ, Lin QD, Bao SM, Zhao AM, Zhang Y, Xiao SJ.

Chin Med J (Engl). 2009 Feb 20;122(4):390-5.

PMID:
19302742
18.

CXCR3 is involved in tubulointerstitial injury in human glomerulonephritis.

Segerer S, Banas B, Wörnle M, Schmid H, Cohen CD, Kretzler M, Mack M, Kiss E, Nelson PJ, Schlöndorff D, Gröne HJ.

Am J Pathol. 2004 Feb;164(2):635-49.

19.
20.

The role of CCR5/CXCR3 expressing CD8+ cells in liver damage and viral control during persistent hepatitis C virus infection.

Larrubia JR, Calvino M, Benito S, Sanz-de-Villalobos E, Perna C, Pérez-Hornedo J, González-Mateos F, García-Garzón S, Bienvenido A, Parra T.

J Hepatol. 2007 Nov;47(5):632-41. Epub 2007 May 24.

PMID:
17560677

Supplemental Content

Support Center